Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMainz Biomed B.V. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$2.80 | -$2.80 | -$2.80 |
| Q2 2025 | 1 | -$2.40 | -$2.40 | -$2.40 |
| Q3 2025 | 1 | -$2.00 | -$2.00 | -$2.00 |
| Q4 2025 | 1 | -$2.00 | -$2.00 | -$2.00 |
Mainz Biomed B.V. Earnings Date And Information
Mainz Biomed B.V. last posted its earnings results on Thursday, December 26th, 2024. The company reported $-15.6 earnings per share for the quarter, missing analysts' consensus estimates of $-4.4 by $11.2. The company had revenue of 214,761 for the quarter and had revenue of 895,479 for the year. Mainz Biomed B.V. has generated $-2 earnings per share over the last year ($-1.62 diluted earnings per share) and currently has a price-to-earnings ratio of -8.9. Mainz Biomed B.V. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 7th, 2025 based on prior year's report dates.
Mainz Biomed B.V. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/08/2024 | Q4 2023 | -$0.32 | -$0.24 | 0.08 | $253,332 | $214,761 |
| 09/29/2023 | Q3 2023 | -$0.39 | $333,333 | $181,669 | ||
| 06/30/2023 | Q2 2023 | -$0.55 | $283,333 | $248,945 | ||
| 03/31/2023 | Q1 2023 | -$0.45 | $266,667 | $250,104 | ||
| 04/07/2023 | Q4 2022 | -$0.58 | $278,500 | $193,281 | ||
| 09/29/2022 | Q3 2022 | -$0.39 | $96,791 | |||
| 06/29/2022 | Q2 2022 | -$0.50 | $139,240 | |||
| 03/30/2022 | Q1 2022 | -$0.42 | $100,565 | |||
| 05/02/2022 | Q4 2021 | -$1.30 | $160,037 | |||
| 09/29/2021 | Q3 2021 | -$0.41 | $144,337 | |||
| 06/29/2021 | Q2 2021 | -$0.02 | $417,311 | |||
| 03/30/2021 | Q1 2021 | -$0.00 | $144,337 | |||
| 12/30/2020 | Q4 2020 | -$0.01 | $123,391 | |||
| 09/29/2020 | Q3 2020 | -$0.01 | $123,391 | |||
| 06/29/2020 | Q2 2020 | -$0.01 | $123,391 | |||
| 03/30/2020 | Q1 2020 | -$0.01 | $123,391 | |||
| 12/30/2019 | Q4 2019 | -$0.02 | $70,348 | |||
| 09/29/2019 | Q3 2019 | -$0.02 | $70,348 | |||
| 06/29/2019 | Q2 2019 | -$0.02 | $70,348 | |||
| 03/30/2019 | Q1 2019 | -$0.02 | $70,348 |
Mainz Biomed B.V. Earnings: FAQ's
When is Mainz Biomed B.V.'s earnings date?
Mainz Biomed B.V. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 7th, 2025 based off last year's report dates.
How can I listen to Mainz Biomed B.V.'s earnings conference
call?
The conference call for Mainz Biomed B.V.'s latest earnings report can be listened to online.
How can I read Mainz Biomed B.V.'s conference call transcript?
The conference call transcript for Mainz Biomed B.V.'s latest earnings report can be read online.
How much revenue does Mainz Biomed B.V. generate each year?
Mainz Biomed B.V. (:MYNZ) has a recorded annual revenue of $895,479.
How much profit does Mainz Biomed B.V. generate each year?
Mainz Biomed B.V. (:MYNZ) has a recorded net income of $895,479. Mainz Biomed B.V. has generated $-1.62 earnings per share over the last four quarters.
What is Mainz Biomed B.V.'s price-to-earnings ratio?
Mainz Biomed B.V. (:MYNZ) has a price-to-earnings ratio of -8.9 and price/earnings-to-growth ratio is -0.6.